VEVO THERAPEUTICS
Dead / Abandoned — Abandoned — after inter partes decision (as of 19 Apr 2024)
What this means for you
This application is over — abandoned 19 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97708773
- Mark type
- Stylized text
- Filed
- 08 Dec 2022
- Published for opposition
- 24 Oct 2023
- Abandoned
- 19 Apr 2024
- Attorney of record
- STEPHEN JADIE COATES
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; research and development in the field of drug discovery; research and development in the field of biotechnology; consulting services in the field of pharmaceutical research and development, drug discovery, and biotechnology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials, drug discovery, and biotechnology; testing of pharmaceuticals; providing online non-downloadable software using artificial intelligence for testing of pharmaceuticals and for drug discovery
Owner
- Vevo Therapeutics, Inc., San Francisco, CA, US
- Vevo Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 19 Apr 2024 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 19 Apr 2024 — ABANDONMENT - AFTER INTER PARTES DECISION
- 19 Apr 2024 — OPPOSITION TERMINATED NO. 999999
- 19 Apr 2024 — OPPOSITION DISMISSED NO. 999999
- 16 Nov 2023 — OPPOSITION INSTITUTED NO. 999999
- 16 Nov 2023 — OPPOSITION PAPERS RECEIVED AT TTAB
- 24 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2023 — PUBLISHED FOR OPPOSITION
- 04 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Sept 2023 — EXAMINER'S AMENDMENT ENTERED
- 19 Sept 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Sept 2023 — EXAMINERS AMENDMENT E-MAILED
- 19 Sept 2023 — EXAMINERS AMENDMENT -WRITTEN
- 14 Sept 2023 — ASSIGNED TO EXAMINER